Predicting malignancy in patients with adrenal tumors using (18)F-FDG-PET/CT SUVmax

BACKGROUND AND OBJECTIVES: (18)F-FDG-PET/CT parameters may help distinguish malignant from benign adrenal tumors, but few have been externally validated or determined based on definitive pathological confirmation. We determined and validated a threshold for (18)F-FDG-PET/CT maximum standard uptake v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Surg Oncol
Main Authors: Vos, Elvira L., Grewal, Ravinder K., Russo, Ashley E., Reidy-Lagunes, Diane, Untch, Brian R., Gavane, Somali C., Boucai, Laura, Geer, Eliza, Gopalan, Anuradha, Chou, Joanne F., Capanu, Marinela, Strong, Vivian E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793554/
https://ncbi.nlm.nih.gov/pubmed/32914407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.26203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados